Table 1.
Demographic and clinical data of the study participants.
| Characteristic | Frequency (n and %) | p value | ||
|---|---|---|---|---|
| Non-SARS-CoV-2 (n = 142) | Mild SARS-CoV-2 (n = 72) | Severe SARS-CoV-2 (n = 86) | Mild against severe SARS-CoV-2 | |
| Nationality | ||||
| Saudi Arabian | 113 (79.6%) | 43 (59.7%) | 44 (51.2%) | |
| Non-Saudi Arabian | 29 (20.4%) | 29 (40.3%) | 42 (48.8%) | |
| Sex | ||||
| Male | 66 (46.5%) | 42 (58.3%) | 75 (87.2%) | ∗∗∗ p < 0.001 |
| Female | 76 (53.5%) | 30 (41.7%) | 11 (12.8%) | |
| Age (years) | ||||
| <20 | 2 (1.4%) | 3 (4.2%) | 0 (0%) | |
| 20–40 | 72 (50.7%) | 50 (69.5%) | 12 (14.0%) | |
| 40–60 | 65 (45.8%) | 12 (16.7%) | 50 (58%) | ∗∗∗ p < 0.001 |
| 60–80 | 3 (2.1%) | 6 (8.3%) | 24 (28%) | ∗∗∗ p < 0.001 |
| >80 | 0 (0%) | 1 (1.3%) | 0 (0%) | |
| BMI (kg/m2) | ||||
| Under weight (< 18.5) | 1 (0.7%) | 1 (1.3%) | 1 (1.2%) | |
| Normal weight (18.5–24.9) | 43 (30.3%) | 25 (34.8%) | 10 (11.6%) | |
| Over weight (25–29.9) | 60 (42.3%) | 22 (30.7%) | 33 (38.4%) | ∗∗ p < 0.01 |
| Obese (≥30) | 38 (26.7%) | 23 (31.9%) | 39 (45.3%) | ∗∗ p < 0.01 |
| Missing | 0 (0%) | 1 (1.3%) | 3 (3.5%) | |
| Chronic diseases | ||||
| No diseases | 108 (76.0%) | 48 (66.7%) | 22 (25.6%) | |
| Diabetes mellitus (DM) | 15 (10.6%) | 6 (8.3%) | 44 (51.2%) | ∗∗∗ p < 0.001 |
| Hypertension (HT) | 14 (9.6%) | 7 (9.7%) | 32 (37.2%) | ∗∗∗ p < 0.001 |
| Bronchial asthma | 5 (3.5%) | 9 (12.5%) | 12 (14%) | |
| Others | 9 (6.3%) | 12 (16.7%) | 18 (20.9%) | |
Data were presented as frequency (n) and percentage (%).